The global multiplex assays market is on track to reach $6.80 billion by 2031, growing at a CAGR of 8.9%, according to the latest report from Meticulous Research®. This growth is propelled by the numerous advantages multiplex assays offer over singleplex assays, their increasing use in companion diagnostics, and the rising prevalence of chronic and infectious diseases worldwide....
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian